{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:43:48Z","timestamp":1792885428486,"version":"4.5.0"},"reference-count":70,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>With acute care utilization and mortality rates increasing among people with opioid use disorder, hospital addiction consult services can provide an important touchpoint for care, potentially leading to improved outcomes.<\/jats:p><\/jats:sec>Objective<\/jats:title>To study the effectiveness of interprofessional hospital addiction consultation services on postdischarge acute care utilization and mortality.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>In this pragmatic stepped-wedge cluster randomized implementation and effectiveness (hybrid type 1) clinical trial, 6 New York City public hospitals were randomized to an intervention start date, and outcomes were compared during treatment as usual (TAU) and intervention conditions. Participants included adults with hospitalizations identified in Medicaid claims data between October 2017 and January 2021. Eligible patients had an admission or discharge diagnosis of opioid use disorder or opioid poisoning or adverse effects, were hospitalized at least 1 night in a medical or surgical inpatient unit, and were not receiving medication for opioid use disorder before hospitalization.<\/jats:p><\/jats:sec>Intervention<\/jats:title>Hospitals implemented the Consult for Addiction Treatment and Care in Hospitals (CATCH) program, an interprofessional inpatient addiction consult service providing specialty care for substance use disorders, with teams consisting of a medical clinician, social worker or addiction counselor, and peer counselor.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Acute care utilization (hospitalizations and emergency department [ED] visits) and mortality rates (all-cause deaths, overdose deaths, and opioid-involved overdose deaths) 1 year after hospital discharge. Data for the eligible patients were analyzed July 2023 to September 2024.<\/jats:p><\/jats:sec>Results<\/jats:title>In total, 1355 eligible admissions were identified (968 [71.4%] men; mean [SD] age, 46.6 [12.4] years). A majority of patients (835 [61.5%]) had at least 1 subsequent hospitalization or ED visit. There were 113 deaths, including 34 overdose deaths (30.1%), of which 28 (82.4%) involved opioids. ED admissions were lower in the intervention period compared with TAU (incidence rate ratio, 0.79 [95% CI, 0.72-0.88]; P<\/jats:italic>\u2009&amp;lt;\u2009.001). There were no statistically significant differences between CATCH and TAU periods in numbers of hospitalizations (incidence rate ratio, 0.99 [95% CI, 0.87-1.13]) or mortality (eg, hazard ratio for all-cause death, 1.14 [95% CI, 0.98-1.92]).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this prespecified secondary analysis of a cluster randomized clinical trial, postdischarge ED visits decreased with the CATCH program, highlighting the potential of hospital-based addiction consult services to address needs of patients with opioid use. Nonetheless, high rates of acute care utilization and mortality persisted, underscoring the need for comprehensive care strategies that extend beyond the hospital walls, and addressing the complex health and social needs of individuals with opioid use.<\/jats:p><\/jats:sec>Trial Registration<\/jats:title>ClinicalTrials.gov Identifier: NCT03611335<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.25222","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T15:00:29Z","timestamp":1754492429000},"page":"e2525222","source":"Crossref","is-referenced-by-count":11,"title":["Addiction Consult Services, Mortality, and Acute Care Utilization in Inpatients With Opioid Use Disorder"],"prefix":"10.1001","volume":"8","author":[{"given":"Yasna","family":"Rostam-Abadi","sequence":"first","affiliation":[{"name":"Department of Population Health, NYU Grossman School of Medicine, New York, New York"},{"name":"Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scarlett","family":"Wang","sequence":"additional","affiliation":[{"name":"NYU Robert F. Wagner Graduate School of Public Service, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"King","sequence":"additional","affiliation":[{"name":"Department of Population Health, NYU Grossman School of Medicine, New York, New York"},{"name":"Office of Behavioral Health, New York City Health + Hospitals, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roopa","family":"Kalyanaraman Marcello","sequence":"additional","affiliation":[{"name":"Office of Population Health, New York City Health + Hospitals, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen","family":"Van Wye","sequence":"additional","affiliation":[{"name":"Bureau of Vital Statistics, New York City Department of Health and Mental Hygiene, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellenie","family":"Tuazon","sequence":"additional","affiliation":[{"name":"Bureau of Alcohol and Drug Use Prevention, Care, and Treatment, New York City Department of Health and Mental Hygiene, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Bureau of Vital Statistics, New York City Department of Health and Mental Hygiene, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Cooke","sequence":"additional","affiliation":[{"name":"Office of Population Health, New York City Health + Hospitals, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medha","family":"Mazumdar","sequence":"additional","affiliation":[{"name":"Department of Population Health, NYU Grossman School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaddeus","family":"Tarpey","sequence":"additional","affiliation":[{"name":"Department of Population Health, NYU Grossman School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Billings","sequence":"additional","affiliation":[{"name":"NYU Robert F. Wagner Graduate School of Public Service, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Appleton","sequence":"additional","affiliation":[{"name":"Department of Population Health, NYU Grossman School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Fernando","sequence":"additional","affiliation":[{"name":"Department of Population Health, NYU Grossman School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adetayo","family":"Fawole","sequence":"additional","affiliation":[{"name":"Department of Population Health, NYU Grossman School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"Office of Behavioral Health, New York City Health + Hospitals, New York, New York"},{"name":"Enterprise Analytics, Mass General Brigham, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Barron","sequence":"additional","affiliation":[{"name":"Office of Behavioral Health, New York City Health + Hospitals, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Schatz","sequence":"additional","affiliation":[{"name":"Office of Behavioral Health, New York City Health + Hospitals, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"McNeely","sequence":"additional","affiliation":[{"name":"Department of Population Health, NYU Grossman School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"issue":"5","key":"zoi250714r2","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1001\/jamapsychiatry.2019.4170","article-title":"All-cause and cause-specific mortality among people using extramedical opioids: a systematic review and meta-analysis.","volume":"77","author":"Larney","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"zoi250714r3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229174","article-title":"National U.S. time-trends in opioid use disorder hospitalizations and associated healthcare utilization and mortality.","volume":"15","author":"Singh","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"zoi250714r4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.annemergmed.2019.04.020","article-title":"One-year mortality of patients after emergency department treatment for nonfatal opioid overdose.","volume":"75","author":"Weiner","year":"2020","journal-title":"Ann Emerg Med"},{"issue":"4","key":"zoi250714r5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/ADM.0000000000000312","article-title":"High mortality among patients with opioid use disorder in a large healthcare system.","volume":"11","author":"Hser","year":"2017","journal-title":"J Addict Med"},{"issue":"6","key":"zoi250714r6","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/add.14892","article-title":"Frequency of health-care utilization by adults who use illicit drugs: a systematic review and meta-analysis.","volume":"115","author":"Lewer","year":"2020","journal-title":"Addiction"},{"issue":"5","key":"zoi250714r7","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1097\/ALN.0000000000002136","article-title":"Opioid abuse or dependence increases 30-day readmission rates after major operating room procedures: a National Readmissions Database study.","volume":"128","author":"Gupta","year":"2018","journal-title":"Anesthesiology"},{"issue":"2","key":"zoi250714r8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11414-013-9323-5","article-title":"Hospital readmission among Medicaid patients with an index hospitalization for mental and\/or substance use disorder.","volume":"40","author":"Mark","year":"2013","journal-title":"J Behav Health Serv Res"},{"issue":"1","key":"zoi250714r9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/ADM.0b013e318231de51","article-title":"Acute care hospital utilization among medical inpatients discharged with a substance use disorder diagnosis.","volume":"6","author":"Walley","year":"2012","journal-title":"J Addict Med"},{"issue":"8","key":"zoi250714r10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.27488","article-title":"Use of medication for opioid use disorder among adults with past-year opioid use disorder in the US, 2021.","volume":"6","author":"Jones","year":"2023","journal-title":"JAMA Netw Open"},{"key":"zoi250714r11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jsat.2018.06.008","article-title":"US hospital discharges documenting patient opioid use disorder without opioid overdose or treatment services, 2011-2015.","volume":"92","author":"Peterson","year":"2018","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"zoi250714r12","doi-asserted-by":"publisher","first-page":"184","DOI":"10.12788\/jhm.3311","article-title":"A call to action: hospitalists\u2019 role in addressing substance use disorder.","volume":"15","author":"Englander","year":"2020","journal-title":"J Hosp Med"},{"issue":"1","key":"zoi250714r13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13722-023-00386-x","article-title":"Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation.","volume":"18","author":"Jakubowski","year":"2023","journal-title":"Addict Sci Clin Pract"},{"key":"zoi250714r14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.12.031","article-title":"Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis.","volume":"160","author":"Yarborough","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"zoi250714r15","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1007\/s11606-020-05815-0","article-title":"Opioid agonist therapy during hospitalization within the Veterans Health Administration: a pragmatic retrospective cohort analysis.","volume":"35","author":"Priest","year":"2020","journal-title":"J Gen Intern Med"},{"key":"zoi250714r16","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.drugalcdep.2018.08.013","article-title":"Multicomorbidity of chronic diseases and substance use disorders and their association with hospitalization: Results from electronic health records data.","volume":"192","author":"Wu","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"zoi250714r17","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1377\/hlthaff.2015.1424","article-title":"Hospitalizations related to opioid abuse\/dependence and associated serious infections increased sharply, 2002-12.","volume":"35","author":"Ronan","year":"2016","journal-title":"Health Aff (Millwood)"},{"issue":"4","key":"zoi250714r18","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/ADM.0000000000000915","article-title":"Causes of death in the 12 months after hospital discharge among patients with opioid use disorder.","volume":"16","author":"King","year":"2022","journal-title":"J Addict Med"},{"key":"zoi250714r19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.socscimed.2014.01.010","article-title":"Hospitals as a \u2018risk environment\u2019: an ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs.","volume":"105","author":"McNeil","year":"2014","journal-title":"Soc Sci Med"},{"key":"zoi250714r20","first-page":"S235","article-title":"Cost and utilization outcomes of opioid-dependence treatments.","volume":"17","author":"Baser","year":"2011","journal-title":"Am J Manag Care"},{"issue":"1","key":"zoi250714r21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1940-0640-9-16","article-title":"Costs of care for persons with opioid dependence in commercial integrated health systems.","volume":"9","author":"Lynch","year":"2014","journal-title":"Addict Sci Clin Pract"},{"issue":"12","key":"zoi250714r22","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1111\/j.1360-0443.2007.02025.x","article-title":"Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study.","volume":"102","author":"Davoli","year":"2007","journal-title":"Addiction"},{"key":"zoi250714r23","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2024.209377","article-title":"The addiction consultation service for hospitalized patients with substance use disorder: An integrative review of the evidence.","volume":"163","author":"Danovitch","year":"2024","journal-title":"J Subst Use Addict Treat"},{"issue":"2","key":"zoi250714r24","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/ADM.0000000000000496","article-title":"Role of the hospital in the 21st century opioid overdose epidemic: the addiction medicine consult service.","volume":"13","author":"Priest","year":"2019","journal-title":"J Addict Med"},{"issue":"4","key":"zoi250714r25","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.mcna.2018.03.001","article-title":"Inpatient addiction consult service: expertise for hospitalized patients with complex addiction problems.","volume":"102","author":"Weinstein","year":"2018","journal-title":"Med Clin North Am"},{"issue":"12","key":"zoi250714r26","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1007\/s11606-019-05251-9","article-title":"Inpatient addiction medicine consultation and post-hospital substance use disorder treatment engagement: a propensity-matched analysis.","volume":"34","author":"Englander","year":"2019","journal-title":"J Gen Intern Med"},{"issue":"9","key":"zoi250714r27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0256793","article-title":"Designing and validating a Markov model for hospital-based addiction consult service impact on 12-month drug and non-drug related mortality.","volume":"16","author":"King","year":"2021","journal-title":"PLoS One"},{"issue":"8","key":"zoi250714r28","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s11606-017-4077-z","article-title":"Inpatient addiction consultation for hospitalized patients increases post-discharge abstinence and reduces addiction severity.","volume":"32","author":"Wakeman","year":"2017","journal-title":"J Gen Intern Med"},{"issue":"11","key":"zoi250714r29","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1093\/cid\/ciy924","article-title":"Addiction medicine consultations reduce readmission rates for patients with serious infections from opioid use disorder.","volume":"68","author":"Marks","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"1","key":"zoi250714r30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13722-024-00463-9","article-title":"Hospital admissions among patients with comorbid substance use disorders: a secondary analysis of predictors from the NavSTAR Trial.","volume":"19","author":"Nordeck","year":"2024","journal-title":"Addict Sci Clin Pract"},{"issue":"5","key":"zoi250714r31","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/ajad.13540","article-title":"Impact of inpatient addiction psychiatry consultation on opioid use disorder outcomes.","volume":"33","author":"Kast","year":"2024","journal-title":"Am J Addict"},{"issue":"1","key":"zoi250714r32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13722-019-0135-7","article-title":"Study protocol for a pragmatic trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) model for engaging patients in opioid use disorder treatment.","volume":"14","author":"McNeely","year":"2019","journal-title":"Addict Sci Clin Pract"},{"issue":"9","key":"zoi250714r33","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1001\/jamainternmed.2024.3422","article-title":"Addiction consultation services for opioid use disorder treatment initiation and engagement: a randomized clinical trial.","volume":"184","author":"McNeely","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"3","key":"zoi250714r34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/MLR.0b013e3182408812","article-title":"Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact.","volume":"50","author":"Curran","year":"2012","journal-title":"Med Care"},{"issue":"7624","key":"zoi250714r35","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"key":"zoi250714r36","doi-asserted-by":"publisher","first-page":"h391","DOI":"10.1136\/bmj.h391","article-title":"The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting.","volume":"350","author":"Hemming","year":"2015","journal-title":"BMJ"},{"key":"zoi250714r37","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2024.209528","article-title":"Attributes of higher- and lower-performing hospitals in the Consult for Addiction Treatment and Care in Hospitals (CATCH) program implementation: A multiple-case study.","volume":"168","author":"Stevens","year":"2025","journal-title":"J Subst Use Addict Treat"},{"key":"zoi250714r40","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.107614","article-title":"Examining opioid-involved overdose mortality trends prior to fentanyl: New York City, 2000-2015.","volume":"205","author":"Tuazon","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"zoi250714r41","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.drugpo.2013.10.015","article-title":"Unintentional opioid overdose deaths in New York City, 2005-2010: a place-based approach to reduce risk.","volume":"25","author":"Siegler","year":"2014","journal-title":"Int J Drug Policy"},{"key":"zoi250714r42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.drugalcdep.2017.12.043","article-title":"Rehospitalization and substance use disorder (SUD) treatment entry among patients seen by a hospital SUD consultation-liaison service.","volume":"186","author":"Nordeck","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"zoi250714r43","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/10826084.2017.1341921","article-title":"Are people who inject drugs frequent users of emergency department services? a cohort study (2008-2013).","volume":"53","author":"Nambiar","year":"2018","journal-title":"Subst Use Misuse"},{"key":"zoi250714r44","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108081","article-title":"Inpatient addiction consultation and post-discharge 30-day acute care utilization.","volume":"213","author":"Weinstein","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"zoi250714r45","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/ADM.0000000000000520","article-title":"The substance use intervention team: a preliminary analysis of a population-level strategy to address the opioid crisis at an academic health center.","volume":"13","author":"Thompson","year":"2019","journal-title":"J Addict Med"},{"issue":"6","key":"zoi250714r46","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.psym.2020.06.019","article-title":"Addiction management in hospitalized patients with intravenous drug use-associated infective endocarditis.","volume":"61","author":"Ray","year":"2020","journal-title":"Psychosomatics"},{"key":"zoi250714r47","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.06.039","article-title":"Touchpoints - opportunities to predict and prevent opioid overdose: a cohort study.","volume":"204","author":"Larochelle","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"zoi250714r49","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/08897077.2019.1635969","article-title":"Retention in care as a quality measure for opioid use disorder.","volume":"40","author":"Martin","year":"2019","journal-title":"Subst Abus"},{"issue":"1","key":"zoi250714r50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00952990.2018.1546862","article-title":"Development of a cascade of care for responding to the opioid epidemic.","volume":"45","author":"Williams","year":"2019","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"3","key":"zoi250714r51","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study.","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann Intern Med"},{"issue":"1","key":"zoi250714r52","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13011-019-0227-0","article-title":"Conceptualizing patient-centered care for substance use disorder treatment: findings from a systematic scoping review.","volume":"14","author":"Marchand","year":"2019","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"1","key":"zoi250714r53","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12954-022-00594-9","article-title":"Meeting people where they are: implementing hospital-based substance use harm reduction.","volume":"19","author":"Perera","year":"2022","journal-title":"Harm Reduct J"},{"issue":"3","key":"zoi250714r54","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s11606-022-07939-x","article-title":"Envisioning Minimally Disruptive Opioid Use Disorder Care.","volume":"38","author":"Englander","year":"2023","journal-title":"J Gen Intern Med"},{"issue":"1","key":"zoi250714r56","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jsat.2009.05.009","article-title":"Substance use treatment barriers for patients with frequent hospital admissions.","volume":"38","author":"Raven","year":"2010","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"zoi250714r57","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1080\/08897077.2022.2074604","article-title":"Opioid use disorder cascade of care framework design: a roadmap.","volume":"43","author":"Williams","year":"2022","journal-title":"Subst Abus"},{"issue":"1","key":"zoi250714r58","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13722-023-00422-w","article-title":"Strategies to support substance use disorder care transitions from acute-care to community-based settings: a scoping review and typology.","volume":"18","author":"Krawczyk","year":"2023","journal-title":"Addict Sci Clin Pract"},{"issue":"7","key":"zoi250714r59","doi-asserted-by":"publisher","first-page":"899","DOI":"10.7326\/M20-5475","article-title":"Preventing hospital readmission for patients with comorbid substance use disorder: a randomized trial.","volume":"174","author":"Gryczynski","year":"2021","journal-title":"Ann Intern Med"},{"issue":"2","key":"zoi250714r60","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1377\/hlthaff.2020.01472","article-title":"Transforming mental health and addiction services.","volume":"40","author":"Alegr\u00eda","year":"2021","journal-title":"Health Aff (Millwood)"},{"key":"zoi250714r61","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103786","article-title":"Has the treatment gap for opioid use disorder narrowed in the U.S.?: a yearly assessment from 2010 to 2019\u201d.","volume":"110","author":"Krawczyk","year":"2022","journal-title":"Int J Drug Policy"},{"issue":"1","key":"zoi250714r62","doi-asserted-by":"publisher","DOI":"10.1093\/haschl\/qxad013","article-title":"Pandemic telehealth flexibilities for buprenorphine treatment: a synthesis of evidence and policy implications for expanding opioid use disorder care in the United States.","volume":"1","author":"Krawczyk","year":"2023","journal-title":"Health Aff Sch"},{"issue":"3","key":"zoi250714r63","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.1016\/S2468-2667(23)00023-3","article-title":"Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy.","volume":"8","author":"Krawczyk","year":"2023","journal-title":"Lancet Public Health"},{"issue":"9","key":"zoi250714r64","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1001\/jamainternmed.2024.3436","article-title":"Opioid use disorder medications after hospitalization-rethinking engagement in care.","volume":"184","author":"Englander","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"1","key":"zoi250714r65","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12954-022-00676-8","article-title":"Intersecting substance use treatment and harm reduction services: exploring the characteristics and service needs of a community-based sample of people who use drugs.","volume":"19","author":"Krawczyk","year":"2022","journal-title":"Harm Reduct J"},{"issue":"3","key":"zoi250714r66","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3122\/jabfm.2022.220303R3","article-title":"Integrating harm reduction into medical care: lessons from three models.","volume":"36","author":"Chang","year":"2023","journal-title":"J Am Board Fam Med"},{"issue":"1","key":"zoi250714r67","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13722-023-00394-x","article-title":"Three decades of research in substance use disorder treatment for syringe services program participants: a scoping review of the literature.","volume":"18","author":"Jakubowski","year":"2023","journal-title":"Addict Sci Clin Pract"},{"issue":"4","key":"zoi250714r68","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/ADM.0000000000000934","article-title":"Low-threshold buprenorphine treatment in a syringe services program: program description and outcomes.","volume":"16","author":"Jakubowski","year":"2022","journal-title":"J Addict Med"},{"issue":"2","key":"zoi250714r69","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.56430","article-title":"Effect of a co-located bridging recovery initiative on hospital length of stay among patients with opioid use disorder: the BRIDGE randomized clinical trial.","volume":"7","author":"Marcovitz","year":"2024","journal-title":"JAMA Netw Open"},{"key":"zoi250714r55","volume-title":"Evidence Brief: Barriers and Facilitators to Use of Medications for Opioid Use Disorder","author":"Mackey","year":"2019"},{"key":"zoi250714r1","unstructured":"Ahmad? FB, Cisewski? JA, Rossen? LM, Sutton? P. Provisional drug overdose death counts. Centers for Disease Control and Prevention National Center for Health Statistics. 2025. Accessed May 8, 2025. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm"},{"key":"zoi250714r38","unstructured":"Tools archive for the Chronic Condition Indicator Refined for ICD-10-CM. Agency for Healthcare Research and Quality: Healthcare Cost and Utilization project. Accessed July 18, 2025. http:\/\/www.hcup-us.ahrq.gov\/toolssoftware\/chronic_icd10\/chronic_icd10_archive.jsp"},{"key":"zoi250714r39","unstructured":"Tuazon? E, Bauman? M, Sun? T, . Unintentional drug poisoning (overdose) deaths in New York City in 2022. NYC Health Epi Data Brief, No. 137. September 2023. Accessed June 17, 2025. https:\/\/www.nyc.gov\/assets\/doh\/downloads\/pdf\/epi\/databrief137.pdf"},{"key":"zoi250714r48","unstructured":"Askari? MS, Bauman? M, Ko? C, Tuazon? E, Mantha? S, Harocopos? A. Unintentional drug poisoning (overdose) deaths in New York City in 2021. NYC Health Epi Data Brief, No. 133. January 2023. Accessed July 7, 2024. https:\/\/www.nyc.gov\/assets\/doh\/downloads\/pdf\/epi\/databrief133.pdf"},{"key":"zoi250714r70","unstructured":"Katz? M. NYC Health + Hospitals. Mayor's management report, 2023. Accessed June 26, 2025. https:\/\/www.nyc.gov\/assets\/operations\/downloads\/pdf\/mmr2023\/hhc.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2837321\/rostamabadi_2025_oi_250714_1753891359.65051.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T15:00:31Z","timestamp":1754492431000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2837321"}},"subtitle":["A Secondary Analysis of a Cluster Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":70,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.25222","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]}}}